A Central Role for TRPM4 in Ca-Signal Amplification and Vasoconstriction

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Feb 15

PMID 35163382

Authors

Tamas Csipo

Agnes Czikora

Gabor A Fulop

Hajnalka Gulyas

Ibolya Rutkai

Eniko Pasztorne Toth

Robert Porszasz

Andrea Szalai

Kata Bolcskei

Zsuzsanna Helyes

Erika Pinter

Zoltan Papp

Zoltan Ungvari

Attila Toth

Affiliations

Soon will be listed here.

Abstract

Transient receptor potential melastatin-4 (TRPM4) is activated by an increase in intracellular Ca concentration and is expressed on smooth muscle cells (SMCs). It is implicated in the myogenic constriction of cerebral arteries. We hypothesized that TRPM4 has a general role in intracellular Ca signal amplification in a wide range of blood vessels. TRPM4 function was tested with the TRPM4 antagonist 9-phenanthrol and the TRPM4 activator A23187 on the cardiovascular responses of the rat, in vivo and in isolated basilar, mesenteric, and skeletal muscle arteries. TRPM4 inhibition by 9-phenanthrol resulted in hypotension and a decreased heart rate in the rat. TRPM4 inhibition completely antagonized myogenic tone development and norepinephrine-evoked vasoconstriction, and depolarization (high extracellular KCl concentration) evoked vasoconstriction in a wide range of peripheral arteries. Vasorelaxation caused by TRPM4 inhibition was accompanied by a significant decrease in intracellular Ca concentration, suggesting an inhibition of Ca signal amplification. Immunohistochemistry confirmed TRPM4 expression in the smooth muscle cells of the peripheral arteries. Finally, TRPM4 activation by the Ca ionophore A23187 was competitively inhibited by 9-phenanthrol. In summary, TRPM4 was identified as an essential Ca-amplifying channel in peripheral arteries, contributing to both myogenic tone and agonist responses. These results suggest an important role for TRPM4 in the circulation. The modulation of TRPM4 activity may be a therapeutic target for hypertension. Furthermore, the Ca ionophore A23187 was identified as the first high-affinity (nanomolar) direct activator of TRPM4, acting on the 9-phenanthrol binding site.

Citing Articles

RELATIONSHIP BETWEEN TRPM4 RS8104571 GENOTYPE, CIRCULATING TRPM4 AND SUR1, AND CLINICAL OUTCOME FOLLOWING TRAUMATIC BRAIN INJURY.

Krocker J, Cotton M, Ashley J, Schriner J, Osborn B, Wang Y Shock. 2024; 63(1):43-51.

PMID: 39227352 PMC: 11742263. DOI: 10.1097/SHK.0000000000002468.

TRPM4 mRNA stabilization by METTL3-mediated m6A modification promotes calcific aortic valve inflammation.

Wu J, Huang H, Yang W, Xue T, Wang W, Zheng G Heliyon. 2024; 10(11):e31871.

PMID: 38868032 PMC: 11167295. DOI: 10.1016/j.heliyon.2024.e31871.

Sex-specific cardiovascular remodeling leads to a divergent sex-dependent development of heart failure in aged hypertensive rats.

Kovacs A, Zhazykbayeva S, Herwig M, Fulop G, Csipo T, Olah N Geroscience. 2024; 46(5):4543-4561.

PMID: 38656649 PMC: 11336029. DOI: 10.1007/s11357-024-01160-w.

Ion Channels in the Development and Remodeling of the Aortic Valve.

Simard C, Aize M, Chaigne S, Bangando H, Guinamard R Int J Mol Sci. 2023; 24(6).

PMID: 36982932 PMC: 10055105. DOI: 10.3390/ijms24065860.

TRPM4 Participates in Irradiation-Induced Aortic Valve Remodeling in Mice.

Bangando H, Simard C, Aize M, Lebrun A, Manrique A, Guinamard R Cancers (Basel). 2022; 14(18).

PMID: 36139640 PMC: 9497207. DOI: 10.3390/cancers14184477.

References

Cheng H, Beck A, Launay P, Gross S, Stokes A, Kinet J . TRPM4 controls insulin secretion in pancreatic beta-cells. Cell Calcium. 2006; 41(1):51-61. PMC: 5663640. DOI: 10.1016/j.ceca.2006.04.032. View

Liu H, El Zein L, Kruse M, Guinamard R, Beckmann A, Bozio A . Gain-of-function mutations in TRPM4 cause autosomal dominant isolated cardiac conduction disease. Circ Cardiovasc Genet. 2010; 3(4):374-85. DOI: 10.1161/CIRCGENETICS.109.930867. View

Nilius B, Prenen J, Tang J, Wang C, Owsianik G, Janssens A . Regulation of the Ca2+ sensitivity of the nonselective cation channel TRPM4. J Biol Chem. 2004; 280(8):6423-33. DOI: 10.1074/jbc.M411089200. View

Vennekens R, Nilius B . Insights into TRPM4 function, regulation and physiological role. Handb Exp Pharmacol. 2007; (179):269-85. DOI: 10.1007/978-3-540-34891-7_16. View

Warshaw D, Mulvany M, Halpern W . Mechanical and morphological properties of arterial resistance vessels in young and old spontaneously hypertensive rats. Circ Res. 1979; 45(2):250-9. DOI: 10.1161/01.res.45.2.250. View

Burris S, Wang Q, Bulley S, Neeb Z, Jaggar J . 9-Phenanthrol inhibits recombinant and arterial myocyte TMEM16A channels. Br J Pharmacol. 2015; 172(10):2459-68. PMC: 4409899. DOI: 10.1111/bph.13077. View

Ding X, Ban T, Liu Z, Lou J, Tang L, Wang J . Transient Receptor Potential Melastatin 4 (TRPM4) Contributes to High Salt Diet-Mediated Early-Stage Endothelial Injury. Cell Physiol Biochem. 2017; 41(2):835-848. DOI: 10.1159/000459695. View

Launay P, Cheng H, Srivatsan S, Penner R, Fleig A, Kinet J . TRPM4 regulates calcium oscillations after T cell activation. Science. 2004; 306(5700):1374-7. DOI: 10.1126/science.1098845. View

Reading S, Brayden J . Central role of TRPM4 channels in cerebral blood flow regulation. Stroke. 2007; 38(8):2322-8. DOI: 10.1161/STROKEAHA.107.483404. View

10.

Li Y, Baylie R, Tavares M, Brayden J . TRPM4 channels couple purinergic receptor mechanoactivation and myogenic tone development in cerebral parenchymal arterioles. J Cereb Blood Flow Metab. 2014; 34(10):1706-14. PMC: 4269733. DOI: 10.1038/jcbfm.2014.139. View

11.

Launay P, Fleig A, Perraud A, Scharenberg A, Penner R, Kinet J . TRPM4 is a Ca2+-activated nonselective cation channel mediating cell membrane depolarization. Cell. 2002; 109(3):397-407. DOI: 10.1016/s0092-8674(02)00719-5. View

12.

Clapham D, Julius D, Montell C, Schultz G . International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels. Pharmacol Rev. 2005; 57(4):427-50. DOI: 10.1124/pr.57.4.6. View

13.

Garland C, Smirnov S, Bagher P, Lim C, Huang C, Mitchell R . TRPM4 inhibitor 9-phenanthrol activates endothelial cell intermediate conductance calcium-activated potassium channels in rat isolated mesenteric artery. Br J Pharmacol. 2014; 172(4):1114-23. PMC: 4314199. DOI: 10.1111/bph.12985. View

14.

Guinamard R, Bouvagnet P, Hof T, Liu H, Simard C, Salle L . TRPM4 in cardiac electrical activity. Cardiovasc Res. 2015; 108(1):21-30. DOI: 10.1093/cvr/cvv213. View

15.

Grand T, Demion M, Norez C, Mettey Y, Launay P, Becq F . 9-phenanthrol inhibits human TRPM4 but not TRPM5 cationic channels. Br J Pharmacol. 2008; 153(8):1697-705. PMC: 2438271. DOI: 10.1038/bjp.2008.38. View

16.

Bulley S, Neeb Z, Burris S, Bannister J, Thomas-Gatewood C, Jangsangthong W . TMEM16A/ANO1 channels contribute to the myogenic response in cerebral arteries. Circ Res. 2012; 111(8):1027-36. PMC: 3666568. DOI: 10.1161/CIRCRESAHA.112.277145. View

17.

Earley S . Vanilloid and melastatin transient receptor potential channels in vascular smooth muscle. Microcirculation. 2010; 17(4):237-49. PMC: 2925403. DOI: 10.1111/j.1549-8719.2010.00026.x. View

18.

Guinamard R, Hof T, Del Negro C . The TRPM4 channel inhibitor 9-phenanthrol. Br J Pharmacol. 2014; 171(7):1600-13. PMC: 3966741. DOI: 10.1111/bph.12582. View

19.

Nilius B, Mahieu F, Prenen J, Janssens A, Owsianik G, Vennekens R . The Ca2+-activated cation channel TRPM4 is regulated by phosphatidylinositol 4,5-biphosphate. EMBO J. 2006; 25(3):467-78. PMC: 1383543. DOI: 10.1038/sj.emboj.7600963. View

20.

Guinamard R, Demion M, Magaud C, Potreau D, Bois P . Functional expression of the TRPM4 cationic current in ventricular cardiomyocytes from spontaneously hypertensive rats. Hypertension. 2006; 48(4):587-94. DOI: 10.1161/01.HYP.0000237864.65019.a5. View